Abstract
BACKGROUND CONTEXT: There continues to be uncertainty regarding the cost-effectiveness of treatments for Adult Symptomatic Lumbar Scoliosis (ASLS). Nonoperative care provides little health related quality of life (HRQOL) benefit; although these patients may have worsened without treatment. Surgery improves HRQOL, but is costly with high revision rates. This study explores this issue via a cost-effectiveness analysis using data from an NIH sponsored trial.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
